ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
Latest News
DOE announces NEPA exclusion for advanced reactors
The Department of Energy has announced that it is establishing a categorical exclusion for the application of National Environmental Policy Act (NEPA) procedures to the authorization, siting, construction, operation, reauthorization, and decommissioning of advanced nuclear reactors.
According to the DOE, this significant change, which goes into effect today, “is based on the experience of DOE and other federal agencies, current technologies, regulatory requirements, and accepted industry practice.”
B.F. Peterman, J.R. Johnson, R.G.C. McElroy
Fusion Science and Technology | Volume 8 | Number 2 | September 1985 | Pages 2557-2563
Environmental Study | Proceedings of the Second National Topical Meeting on Tritium Technology in Fission, Fusion and Isotopic Applications (Dayton, Ohio, April 30 to May 2, 1985) | doi.org/10.13182/FST85-A24664
Articles are hosted by Taylor and Francis Online.
This paper describes a study on metabolism of inhaled tritiated hydrogen gas (HT) in mammals. Rats and human volunteers were exposed to HT gas for periods from one minute to ten minutes. The amount of HT that was oxidized in vivo was estimated by measuring the concentration of HTO in urine. No significant quantities of tritiated organic compounds resulting from HT gas inhalation were observed in tissues of rats and it is assumed that this holds true for humans also. The fraction of inhaled HT converted to HTO in human volunteers was found to be about 1 × 10−4 indicating that the dose from the HTO that resulted from HT oxidiation is a significant component of the effective dose equivalent.